Which has the lower trailing P/E, CVS or ISRG?

CVS has the lower trailing P/E: CVS trades at 25.04 and ISRG at 42.00. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CVS or ISRG?

Over the past five years, ISRG grew revenue faster — CVS at a 8.32% CAGR versus ISRG at 16.41%.

Does CVS or ISRG pay a bigger dividend?

CVS pays a dividend (2.79% yield), while ISRG has no payments in the available dividend history.

Is CVS or ISRG more profitable?

ISRG runs the higher net margin — CVS at 1.18% versus ISRG at 28.45%.

How have CVS and ISRG total returns compared?

Over the past 10 years, CVS delivered 3.54% and ISRG delivered 16.97% annualized total return. Past performance doesn't predict future results.

CVS Health Corp. (CVS) vs Intuitive Surgical, Inc. (ISRG)

A side-by-side comparison of CVS Health Corp. and Intuitive Surgical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

CVS

CVS Health Corp.

$120.78B

$94.66HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

ISRG

Intuitive Surgical, Inc.

$130.41B

$369.15HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — CVS vs ISRG

growth of $100 · dividends reinvested · last 10y

CVS +39.3% (+3.4%/yr)ISRG +372.7% (+16.8%/yr)ISRG compounded faster over this window

CVS ISRG

CVS vs ISRG: by the numbers

•ISRG is the larger company ($130.41B vs $120.78B market cap).
•CVS trades at the lower trailing earnings multiple (25.04 vs 42.00 P/E), one valuation lens rather than an overall verdict.
•ISRG converts more revenue to profit (28.45% vs 1.18% net margin).
•ISRG grew revenue faster over the past five years (16.41% vs 8.32% CAGR).
•CVS pays a dividend (2.79% yield), while ISRG has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CVS	ISRG
P/E ratio	25.04	42.00
Forward P/E	11.83	34.18
P/S ratio	0.29	11.82
P/B ratio	1.52	7.18
EV / EBITDA	14.50	30.16
FCF yield	9.74%	2.47%

Profitability

Metric	CVS	ISRG
Gross margin	14.15%	66.68%
Operating margin	2.00%	31.28%
Net margin	1.18%	28.45%
ROE	6.16%	17.28%
ROIC	4.14%	15.11%

Dividends

Metric	CVS	ISRG
Dividend yield	2.79%	N/A
Payout ratio	70.37%	N/A

Growth (annualized)

Metric	CVS	ISRG
Revenue CAGR (5Y)	8.32%	16.41%
EPS CAGR (5Y)	-23.89%	21.51%
FCF CAGR (5Y)	-10.28%	14.17%
Total return CAGR (5Y)	6.05%	1.11%

Frequently asked

Which has the lower trailing P/E, CVS or ISRG?: CVS has the lower trailing P/E: CVS trades at 25.04 and ISRG at 42.00. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CVS or ISRG?: Over the past five years, ISRG grew revenue faster — CVS at a 8.32% CAGR versus ISRG at 16.41%.
Does CVS or ISRG pay a bigger dividend?: CVS pays a dividend (2.79% yield), while ISRG has no payments in the available dividend history.
Is CVS or ISRG more profitable?: ISRG runs the higher net margin — CVS at 1.18% versus ISRG at 28.45%.
How have CVS and ISRG total returns compared?: Over the past 10 years, CVS delivered 3.54% and ISRG delivered 16.97% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CVS analysis Full ISRG analysis Interactive comparison tool

Dig into the metrics

CVS Health P/E ratio Intuitive Surgical P/E ratio CVS Health dividend yield CVS Health ROE Intuitive Surgical ROE CVS Health operating margin Intuitive Surgical operating margin CVS Health revenue growth Intuitive Surgical revenue growth CVS Health free cash flow Intuitive Surgical free cash flow

CVS Health & Intuitive Surgical appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.